Acasă › Cancer pulmonar cu celule non-pătrate › Florida › Deltona
Studii clinice pentru Cancer pulmonar cu celule non-pătrate în Deltona, FL
15 studii pentru Cancer pulmonar cu celule non-pătrate caută participanți în și în jurul orașului Deltona (în aproximativ 50 km). Deschideți un studiu pentru a vedea criteriile de eligibilitate și cum să contactați echipa de cercetare.
Text oficial al studiului (în engleză)
Study to Evaluate Adverse Events and Efficacy of Intravenous (IV) Telisotuzumab Adizutecan in Combination With a PD-1 Immune Checkpoint Inhibitor in Adult Participants With Advanced or Metastatic Non-Squamous NSCLC With No Prior Treatment for Advanced Disease, and No Actionable Genomic Alterations
În curs de recrutareFaza 1/2
- Mid Florida Hematology And Oncology Center /ID# 273777, Orange City · La 4 mi distanță
A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)
În curs de recrutareFaza 3
- Mid Florida Hematology and Oncology Center ( Site 0018), Orange City · La 4 mi distanță
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
În curs de recrutareFaza 3
- Alpha Clinical Research Centers LLC, Orange City · La 4 mi distanță
- Florida Cancer Specialists, Orange City · La 4 mi distanță
- Mid Florida Hematology and Oncology Center, Orange City · La 4 mi distanță
- și încă 1
This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.
În curs de recrutareFaza 3
- Mid Florida Hematology and Oncology Center, Orange City · La 4 mi distanță
Symbiotic-Lung-20: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Different Anticancer Agents in Advanced Cancers
În curs de recrutareFaza 1/2
- Mid Florida Hematology and Oncology Center, Orange City · La 4 mi distanță
Pan-tumor MRD Study
În curs de recrutareStudiu observațional
- Mid Florida Cancer Centers, Orange City · La 4 mi distanță
Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC With High PD-L1 Expression (TC ≥ 50%) and Without Actionable Genomic Alterations
În curs de recrutareFaza 3
- Research Site, Orange City · La 4 mi distanță
Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer
În curs de recrutareFaza 2/3
- Mid Florida Cancer Centers, Orange City · La 4 mi distanță
A Study of Adagrasib Plus Pembrolizumab Plus Chemotherapy vs. Placebo Plus Pembrolizumab Plus Chemotherapy in Participants With Previously Untreated Non-squamous Non-small Cell Lung Cancer With KRAS G12C Mutation (KRYSTAL-4)
În curs de recrutareFaza 3
- Mid Florida Hematology and Oncology Center, Orange City · La 4 mi distanță
Beamion LUNG-3: Adjuvant Zongertinib vs Standard Treatment in People With Completely Resected Stage II-IIIB NSCLC Harboring Activating HER2 TKD Mutations
În curs de recrutareFaza 3
- Mid Florida Hematology and Oncology Center, Orange City · La 4 mi distanță
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
În curs de recrutareFaza 2/3
- Local Institution - 007-926-B, Daytona Beach · La 26 mi distanță
Study of Trastuzumab Deruxtecan, Pembrolizumab, and Platinum-based Chemotherapy in First-line HER2 Overexpressing Non-small Cell Lung Cancer
În curs de recrutareFaza 3
- Mid-Florida Hematology & Oncology Centers, P.A., Orange City · La 4 mi distanță
Phase III, Open-label Study of First-line Osimertinib With or Without Datopotamab Deruxtecan for EGFRm Locally Advanced or Metastatic Non-small Cell Lung Cancer
În curs de recrutareFaza 3
- Research Site, Orange City · La 4 mi distanță
Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)
În curs de recrutareFaza 1/2
- Mid Florida Hematology and Oncology Center, Orange City · La 4 mi distanță
Efficacy & Safety of Olvimulogene Nanivacirepvec & Platinum-doublet + Physician's Choice of Immune Checkpoint Inhibitor Compared to Docetaxel in NSCL Cancer
În curs de recrutareFaza 2
- Mid Florida Hematology and Oncology Center, Orange City · La 4 mi distanță
Studii pentru Cancer pulmonar cu celule non-pătrate în alte orașe
- Houston, TX145 studii
- New York City, NY120 studii
- Arlington, VA104 studii
- Nashville, TN97 studii
- Boston, MA90 studii
- Los Angeles, CA87 studii
- St. Louis, MO73 studii
- Chicago, IL61 studii
- Baltimore, MD60 studii
- San Antonio, TX59 studii
- Columbus, OH56 studii
- Washington, DC55 studii
Alte studii în Deltona
- Obezitate11 studii
- Diabet de tip 210 studii
- Boala Alzheimer10 studii
- Supraponderalitate9 studii
- Cancer de sân8 studii
- Cancer pulmonar8 studii
- Cancer (toate tipurile)7 studii
- Hipertensiune arterială5 studii
- Osteoartrită a genunchiului5 studii
- Cancer metastatic5 studii
- Melanom5 studii
- BPOC4 studii
Sursă: ClinicalTrials.gov, date preluate la 5 oct. 2026. Fiecare studiu are propriile criterii de eligibilitate; echipa de cercetare decide cine poate participa.